Living With Diabetic Retinopathy: Blood Sugar, Blood Pressure and the Eye Check Calendar

The letter arrives a couple of weeks after the screening photos. Two lines stand out: “background retinopathy detected” and “see you in 12 months.” Most people read those lines three times. The first reading brings a jolt. The second brings the obvious question: how can there be damage when everything looks fine? The third settles into something more useful: what do I do between now and the next appointment?

That gap is where living with diabetic retinopathy actually happens. Not in the clinic chair, but at the kitchen table where the glucose meter sits, in the pharmacy line where blood pressure gets rechecked, and in the diary where the next eye check is either written down or quietly forgotten.

This explainer walks through what the condition is, why sugar and pressure matter more than any eye drop, how the stages are described, and what the check calendar should look like for you. The decisions stay with your diabetes and eye teams; the aim here is to make their explanations easier to follow.

What living with diabetic retinopathy really means

A diagnosis of diabetic retinopathy describes what a clinician sees on the retina, the light-sensing layer lining the back of the eye. It is not, by itself, a statement about how well you see. The NHS notes that early retinopathy often causes no symptoms at all, and that many people are told about it only because a screening photograph picked it up.

That matters for how you frame the years ahead. Diabetes has already given you a set of numbers to watch. Retinopathy adds a second layer of appointments and a reason to care about those numbers for the sake of your sight as well as your heart and kidneys. The National Eye Institute describes diabetic retinopathy as a leading cause of blindness among working-age adults in the United States, yet the same source stresses that the risk is strongly shaped by how long someone has had diabetes and how well glucose and blood pressure have been controlled over that time.

Three things sit within your reach. Blood glucose, because high sugar is what injures the tiny vessels in the first place. Blood pressure, because stiff, pressurized vessels leak more. And the eye check calendar, because retinopathy is one of the few serious complications that can be photographed, graded and tracked before it touches vision.

Nothing here should be read as a promise. Some people progress despite doing everything asked of them; others stay stable for decades. What the evidence consistently shows is that the odds shift in your favor when the three levers are pulled steadily rather than in bursts. The rest of this article is about how to pull them.

How diabetic retinopathy works: what actually happens inside the eye

Picture the retina as a sheet of living film wired to the brain. It has one of the highest oxygen demands of any tissue in the body, and it is fed by a lace of capillaries, vessels so narrow that red blood cells pass through in single file.

Years of raised glucose damage the cells that hold those capillaries together. The vessel walls weaken and bulge into tiny pouches called microaneurysms, then start to leak fluid, fat and blood into the retina. The Mayo Clinic describes this as the nonproliferative phase: the existing vessels are misbehaving, but no new ones have appeared.

Leakage near the center of the retina causes a separate problem. The macula is the small central patch responsible for reading, faces and fine detail. When fluid pools there it swells, a condition called diabetic macular edema, and reading vision blurs even when the rest of the retina looks relatively calm.

As more capillaries close off, patches of retina are starved of oxygen. Those patches send out a chemical distress call, chiefly a protein called vascular endothelial growth factor, or VEGF, which tells the eye to grow new vessels. The new vessels are the wrong answer. They are fragile, grow in the wrong places, and bleed into the vitreous, the clear gel that fills the eye. Scar tissue can follow and tug the retina away from the wall of the eye. The Mayo Clinic calls this proliferative diabetic retinopathy, the advanced stage.

Understanding this chain explains every treatment you will hear about. Glucose and pressure control slow the first link. Laser and anti-VEGF medicines target the distress signal and the abnormal vessels. Surgery deals with the bleeding and scarring that come last.

What does diabetic retinopathy look like?

From the outside, nothing. Retinopathy does not redden the eye, change its shape or show in the mirror. This is one reason it slips past people for years.

From the inside, the early stages are also silent. The NHS is direct about this: you may not notice any symptoms until the condition is more advanced. When changes do reach awareness, the Mayo Clinic lists experiences such as spots or dark strings drifting through vision (floaters), blurred or fluctuating sight, dark or empty areas in the visual field, colors that look washed out, and difficulty seeing at night. These are not a self-test. Every one of them has other causes, and their absence proves nothing about your retina.

What your eye specialist sees is more specific. On a retinal photograph, microaneurysms appear as pinpoint red dots. Small hemorrhages look like dots and blots or flame-shaped streaks. Leaked fat forms yellowish patches called hard exudates. Areas of retina that have lost their blood supply show up as fluffy white spots, sometimes called cotton-wool spots. In proliferative disease, fine new vessels can be seen fanning out over the optic nerve or across the retina, and bleeding into the vitreous can obscure the view altogether.

A scan called optical coherence tomography, or OCT, adds a cross-section, a bit like an ultrasound made with light, showing whether the macula is thickened with fluid. That picture can look dramatic on screen while your reading vision still feels acceptable, or vice versa.

Ask to see your images. Most clinics will show you, and understanding what a “dot hemorrhage” or “a little fluid at the macula” looks like turns an abstract letter into something you can follow across visits.

Diabetic retinopathy stages: from stage 1 to proliferative

Clinicians grade retinopathy so that they can decide how closely to watch and when to intervene. Different countries use slightly different labels, which causes confusion when people compare notes online. The NHS uses a three-stage system plus a separate flag for the macula; US specialists more often speak of mild, moderate and severe nonproliferative disease followed by proliferative disease. The table below lines them up.

NHS label	Common US label	What is seen	Typical vision impact
Stage 1: background retinopathy	Mild nonproliferative	A few microaneurysms, perhaps tiny hemorrhages	Usually none
Stage 2: pre-proliferative	Moderate to severe nonproliferative	More widespread hemorrhages, cotton-wool spots, vessel changes	Often none, but risk of progression is high
Stage 3: proliferative	Proliferative	New abnormal vessels, vitreous bleeding, possible scarring or detachment	Can be severe and sudden
Diabetic maculopathy (any stage)	Diabetic macular edema	Fluid or exudates at the macula	Blurred central and reading vision

Two points about this table are worth holding onto. Stages are not a conveyor belt; many people remain at stage 1 for years, and improvement in glucose and blood pressure can stabilize or even quieten early changes, according to the NHS. Second, the macula column sits outside the numbered stages because macular swelling can appear at any point, including alongside otherwise mild disease. Someone can therefore be told they have “early retinopathy” and still be offered treatment because their macula is swollen.

The stage in your letter is a snapshot. The trend across several letters is what your team is really watching.

What are the characteristics of stage 2 diabetic retinopathy?

Stage 2 is the point where the tone of the conversation changes. The NHS describes pre-proliferative retinopathy as “more severe and widespread changes” in the retina’s blood vessels, including bleeding into the retina, with a high risk that vision could eventually be affected if nothing changes.

On photographs, the specialist looks for a handful of features. Hemorrhages become more numerous and appear in all four quadrants of the retina rather than in one corner. Veins may take on a beaded, sausage-like appearance where their walls have weakened. Fine, twisted vessel loops called intraretinal microvascular abnormalities form as the retina tries to reroute blood around blocked capillaries. Cotton-wool spots mark small areas that have lost their supply. None of these is a new vessel yet, which is exactly why this stage carries the prefix “pre.”

Vision at stage 2 is often still normal, and that is the trap. The eye feels fine while the retina is running low on oxygen and preparing to send the VEGF signal that leads to proliferative disease.

What usually changes at this stage is the calendar. The NHS notes that people with pre-proliferative changes may be advised to have screening every 3 or 6 months rather than annually. In some services the person is moved from a photography-based screening program to a hospital eye clinic, where OCT scans and a wider range of tests are available.

The other thing that changes is urgency around the numbers. Stage 2 is the loudest possible reminder that glucose and blood pressure targets are about sight as well as long-term heart risk. Treatment of the eye itself is not automatic at this stage; the decision rests on what the images show and how quickly they are moving.

Blood sugar: the lever that matters most when living with diabetic retinopathy

Ask any retina specialist what protects the retina best and the answer is not an eye treatment. It is glucose control, sustained over years.

The measure most teams use is HbA1c, often shortened to A1c: a blood test reflecting average glucose over roughly the previous 2 to 3 months, expressed as a percentage or in mmol/mol. The Mayo Clinic notes that an A1c of 7% or lower is a common treatment target for many adults with diabetes, while stressing that the right target varies with age, other health conditions and the risk of low glucose. Your own target is a conversation, not a rule pulled from a website.

Two features of glucose control are easy to miss. The first is that the retina remembers. Damage reflects years of exposure, so this year’s improvement pays off slowly, and past periods of high sugar can keep influencing the eye for a while even after control improves. The NHS notes that early retinopathy may stabilize or improve with better control, but the timescale is measured in check-ups, not weeks.

The second is that speed matters. Clinicians often prefer a steady, sustained fall in A1c to a dramatic drop, and they watch the eyes more closely during periods of rapid change, particularly in people who already have significant retinopathy. Anyone starting a new glucose-lowering regimen, including newer injectable classes, should make sure their diabetes team knows the state of their retina.

Continuous glucose monitors add a useful measure called time in range, the share of each day spent within an agreed glucose band. Fewer wild swings tend to mean fewer oxidative hits to the vessel walls. The daily work of eating, moving and taking prescribed medicines as directed is unglamorous. It is also the single most evidence-backed thing you can do for your retina.

Blood pressure and cholesterol: the other two dials

Glucose weakens the retina’s vessels. Pressure decides how hard they are pushed against. That is why blood pressure is the second number on every diabetic eye clinic’s list.

The American Heart Association defines normal blood pressure as below 120/80 mm Hg, “elevated” as 120 to 129 over less than 80, stage 1 hypertension as 130 to 139 or 80 to 89, and stage 2 as 140/90 or higher. Diabetes guidelines generally set an individualized target that often sits below 130/80, though frailty, kidney function and how you tolerate medicines all feed into the number your clinician writes down.

The mechanism is intuitive. Higher pressure means more fluid forced through already leaky capillary walls, more microaneurysms rupturing, and more swelling at the macula. Blood pressure lowering has a strong evidence base for slowing retinopathy progression in people with diabetes, and it does double duty for the kidneys and heart.

Home monitoring helps. A validated upper-arm cuff, readings taken seated after a few minutes of rest, and a written log over a week give your team far more than a single clinic reading taken after a rushed walk from the parking lot.

Cholesterol is the third dial, though its evidence for the eye is less direct than for the heart. Lipid-lowering medicines, chiefly statins, are part of standard vascular protection in diabetes. Some trials have hinted that certain lipid medicines slow retinopathy, but the evidence is not strong enough for any guideline to prescribe them for the eye alone, and no reputable source presents them as an eye treatment. Take them, if prescribed, for the reasons your clinician gives, and view any retinal benefit as a possible bonus rather than the goal.

Smoking belongs in this section too. It narrows vessels, raises pressure and worsens every diabetic complication. Stopping is one of the few changes that helps every organ at once.

How to control diabetic retinopathy day to day

“Control” is the right word. The condition is managed over years, and the management looks less like a hospital and more like an ordinary week.

Start with rhythm. Meals at roughly consistent times, medicines taken as prescribed, and regular movement smooth the glucose curve more than any single heroic effort. The NHS and CDC both frame retinopathy prevention around the same trio: keep blood sugar, blood pressure and cholesterol in the ranges your team sets, and attend every eye check.

Movement deserves a specific note. Most people with retinopathy are encouraged to stay active. In advanced proliferative disease or after recent bleeding, some specialists advise avoiding heavy straining, breath-holding lifts or contact sports for a period. That advice is individual; ask before you assume either way.

Watch the moments of change. A new diagnosis of pregnancy, a new glucose medicine, a hospital stay, a period of illness: each can shift glucose quickly, and each is a moment to tell your eye team as well as your diabetes team.

Keep the paperwork moving. Screening programs rely on correct addresses and contact numbers; a moved house has cost many people a year of monitoring. Write the next eye check into the same calendar you use for everything else.

Look after the rest of the eye. Retinopathy does not protect you from glaucoma or cataract, both of which are more common in diabetes according to the National Eye Institute. Report any new visual change rather than filing it under “probably the retinopathy.”

Finally, be wary of anything sold as reversing retinopathy. Supplements, special diets and devices marketed for this purpose lack good evidence. The NIH Office of Dietary Supplements is a reliable place to check claims about vitamins before spending money or, more importantly, before letting them replace the things that do work.

How often should you have a diabetic eye exam? The check calendar

The honest answer is: as often as your last result says, and never less than the baseline your program sets.

The Mayo Clinic advises a yearly dilated eye exam for people with diabetes even when vision seems normal. In England, the NHS diabetic eye screening program invites everyone with diabetes aged 12 and over, usually once a year; people who have had two consecutive screenings with no retinopathy may be moved to invitations every 2 years, and those with pre-proliferative changes may be seen every 3 or 6 months. Pregnancy resets the schedule: the Mayo Clinic notes that additional exams are often recommended during pregnancy because retinopathy can progress faster, and the NHS screens pregnant women more frequently.

What happens at the check is straightforward. Drops widen the pupil so the retina can be photographed or examined; the NHS warns that vision may be blurred and light-sensitive for several hours afterward, so arrange a lift or public transport rather than driving. Photographs are graded, and in hospital clinics an OCT scan may be added. Occasionally a dye test called fluorescein angiography is used, in which a dye injected into an arm vein highlights leaking or blocked vessels on a rapid series of photographs.

A screening visit is not an eyesight test for glasses, and a routine sight test is not retinopathy screening. Both have their place; only the dilated retinal examination or photograph does this job.

Put the date somewhere you will see it. If a letter does not arrive when expected, chase it. The single most preventable reason for late-diagnosed proliferative disease is a missed year, not a missed medicine.

Who is usually treated, and who is usually asked to watch and wait

Most people living with diabetic retinopathy are not treated in the eye itself. That surprises many patients, and it reflects how the evidence stacks up: for early disease, laser or injections offer little, while glucose and blood pressure control offer a great deal.

Watchful waiting is the usual advice for background (stage 1) retinopathy and for many with pre-proliferative changes without macular swelling. The plan is closer monitoring plus pressure on the numbers. “Wait” here does not mean passivity; it means the treatment is happening at the pharmacy and the kitchen table rather than under a laser.

Treatment of the eye is generally considered in three situations, as outlined by the NHS. First, when macular edema is affecting or threatening central vision. Second, when proliferative disease appears, because new vessels tend to bleed. Third, when complications such as vitreous hemorrhage or retinal detachment have already occurred and need surgery.

Some people are asked to wait even when treatment might otherwise be offered. Someone with very poorly controlled glucose may be advised to stabilize it first, partly because rapid metabolic change can influence the retina. A person with an active eye infection or inflammation will usually have injections postponed. Pregnancy shifts the calculation for some medicines, and anyone recently treated for a stroke or heart attack may be asked to defer certain injections while their physician and retina specialist confer.

None of these are rules you can apply to yourself. They illustrate that the decision weighs the state of the retina, the state of the rest of you, and what the imaging is likely to show at the next visit. Asking “what would make you decide to treat, and what would make you decide to wait?” is a fair question that most specialists welcome.

Laser, eye injections and surgery: what each does

Three families of treatment exist, and each targets a different link in the chain described earlier.

Laser photocoagulation uses focused light to create tiny burns on the retina. In proliferative disease, a scattered pattern across the outer retina (panretinal photocoagulation) reduces the oxygen-starved tissue that produces VEGF, so the signal to grow new vessels quietens. For macular edema, a lighter, targeted laser seals leaking spots. The NHS notes that laser aims to stop the condition worsening rather than restore lost sight, and that side effects can include reduced night vision, reduced peripheral vision and small blind spots, since burned retina no longer works.

Anti-VEGF injections deliver a medicine into the vitreous that blocks vascular endothelial growth factor directly. By mopping up the distress signal they reduce leakage at the macula and can shrink new vessels. The medicines are given as a series over months, with intervals adjusted to what the OCT scan shows; the frequency is entirely a decision for the treating team. Steroid implants are an alternative class that reduce inflammation and leakage, sometimes used when anti-VEGF has not worked or is unsuitable; they carry a higher chance of raising eye pressure and hastening cataract.

Vitrectomy is surgery to remove the vitreous gel, clear blood that will not settle, and peel scar tissue that is pulling on the retina. The NHS describes it as an option when there is significant bleeding or when scarring threatens or causes detachment. Sometimes a gas bubble or oil is left in the eye to hold the retina in place while it heals.

Each option has risks, from infection and raised pressure after injections to cataract after surgery. Alternatives always include continued monitoring with tighter systemic control. The choice sits with your retina specialist, weighing your images against those trade-offs.

What the days and weeks after treatment usually look like

People worry more about the aftermath than the procedure. The typical picture is milder than most expect, though details vary with the treatment and the individual.

After laser, the NHS describes blurred vision for several hours, an aching or gritty eye, and sensitivity to light for a day or so; some people notice small fixed spots or dimmer night vision afterward, which may be permanent and should be discussed beforehand. Most resume ordinary activity the next day, keeping driving off the list until vision has cleared.

After an anti-VEGF injection, the eye may feel scratchy from the antiseptic used to clean it, and a small red patch on the white of the eye is common where the needle entered. Some see a dark bubble or drifting spot for a day, which is the medicine itself settling. The NHS lists eye irritation or discomfort, bleeding inside the eye, floaters and a feeling of something in the eye as possible short-term effects. The rare serious risk is infection, which is why increasing pain, redness or worsening vision in the days afterward should be reported immediately rather than watched.

Vitrectomy takes longer. Vision is often blurry for a period afterward, and if a gas bubble has been placed you may be asked to keep your head in a particular position and told not to fly or travel to high altitude until it has absorbed, because the bubble expands with reduced pressure. The NHS advises that recovery from vitrectomy takes longer than from laser or injections and that vision may take weeks to settle.

Across all three, the calendar tightens: review visits and OCT scans in the following weeks show whether the retina has responded and guide what comes next. Keep the systemic numbers steady through this period; treatment of the eye works best when the vessels behind it are not being freshly injured.

What people often get wrong about diabetic retinopathy

Myths gather around any condition that hides for years. These are the ones eye clinics hear most.

“My vision is fine, so my eyes are fine.” The NHS and Mayo Clinic both stress that retinopathy typically causes no symptoms in its early stages, and that even pre-proliferative disease can leave vision untouched. Comfort is not evidence.

“My sugars are good now, so I can skip the check.” Better control lowers risk; it does not delete years of prior exposure, and the retina can change during periods of improvement. Screening frequency is set by the retina, not by the meter.

“Retinopathy means I will go blind.” The National Eye Institute is clear that with regular exams and control of glucose and blood pressure, many people preserve useful vision for life. Blindness from diabetes is most often the story of missed monitoring.

“A glasses test covers it.” A routine sight test may glimpse the retina, but it is not a dilated, graded retinal examination. The two are different appointments.

“Injections are forever.” Courses are individual. Some people need a series and then long gaps; others need longer treatment. The interval is decided by scans, not by a fixed rule.

“Screens and reading strain the retina.” Retinopathy is a blood vessel disease driven by glucose and pressure. Reading, screens and bright light do not cause it or speed it up.

“Vitamins or a supplement can reverse it.” No supplement has good-quality evidence for treating diabetic retinopathy, and the NIH Office of Dietary Supplements recommends discussing any product with a clinician before use. Money spent there is money not spent on a blood pressure cuff.

“Once treated, it is fixed.” Laser and injections treat complications; the underlying diabetes continues. The calendar and the numbers matter as much after treatment as before.

Questions to ask your care team

A ten-minute appointment goes further when you arrive with questions written down. These are the ones that tend to unlock the most useful conversations.

• Which stage or grade did my latest images show, and how does that compare with last time?
• Is there any swelling at the macula, and does it need treatment or monitoring?
• How often should I be checked from now on, and who sends the invitation?
• What A1c and blood pressure targets are right for me, and why those particular numbers?
• Are any of my current medicines, or ones you are considering, known to affect the retina during periods of rapid glucose change?
• What signs should make me call you the same day rather than wait for the next appointment?
• If treatment is recommended, what is it aiming to do, what are the alternatives including continued monitoring, and what are the main risks?
• How long might a course of injections run, and what would make you extend, pause or stop it?
• Will laser affect my night or side vision, and does that matter for my work or driving?
• Do I need to tell the driver licensing authority about my diagnosis or treatment?
• I am planning a pregnancy, or am pregnant: how does that change the check schedule?
• Can I see my retinal images and scans, and can I have copies for my records?

Bring someone with you if you can. Dilating drops blur reading vision for hours, so a second set of ears and a hand to take notes are practical as well as reassuring. If the answer to any question is “we don’t know yet,” that is a legitimate answer; ask what result at the next visit would settle it.

Above all, make sure your diabetes team and your eye team know about each other’s plans. Retinopathy sits exactly at the join between them.

When to call your doctor

Routine retinopathy is managed by the calendar. A short list of changes should jump the queue and be reported the same day, or through emergency eye services if your clinic is closed.

• A sudden shower of new floaters, especially with flashes of light, which can signal bleeding into the vitreous or a retinal tear.
• A dark curtain, shadow or veil moving across part of your vision, a classic sign of retinal detachment.
• Sudden loss of vision in one eye, or a sudden marked blur that does not clear within minutes.
• Rapidly worsening central vision, such as straight lines looking bent or print becoming smeared over days.
• After an eye injection or surgery: increasing pain, deepening redness, a discharge, or vision that is getting worse rather than better, since these can indicate infection.
• Severe eye pain with a red eye, headache, nausea or halos around lights, which can point to a dangerous rise in eye pressure.

Slower changes also deserve a call, though not an ambulance: a gradual blur that persists more than a few days, new difficulty with night driving, or any visual change during pregnancy.

If you have missed a screening invitation, treat that as a reason to phone as well. Getting back onto the program is quicker than most people fear, and the National Eye Institute and NHS both emphasize that early detection is what makes the difference between monitoring and emergency treatment.

Nothing in this article replaces the judgment of the people who can actually see your retina. Their images, and your steady work on glucose and blood pressure between visits, are what living well with diabetic retinopathy is built on.

Frequently asked questions

What is stage 1 diabetic retinopathy?

Stage 1, called background retinopathy by the NHS, means a few tiny bulges (microaneurysms) have formed in the retina’s small vessels, sometimes with pinpoint bleeding. Vision is usually unaffected and no eye treatment is normally offered. The advice is to keep blood glucose, blood pressure and cholesterol within agreed targets and attend every scheduled screening so any change is caught early.

What are the characteristics of stage 2 diabetic retinopathy?

Stage 2, or pre-proliferative retinopathy, shows more widespread hemorrhages across the retina, beaded veins, abnormal vessel loops and cotton-wool spots marking oxygen-starved patches, but no new vessels yet. Vision is often still normal. The NHS notes a high risk of progression at this stage, so screening may move to every 3 or 6 months and systemic control becomes especially urgent.

What does diabetic retinopathy look like to the person who has it?

Often like nothing at all in the early stages. When it does affect sight, people may describe floaters, blurred or fluctuating vision, dark or empty patches, faded colors or trouble seeing at night, according to the Mayo Clinic. These experiences have many causes and are not a self-test; only a dilated retinal examination or photograph shows what is actually happening.

How to control diabetic retinopathy without eye treatment?

Control comes from the numbers rather than the eye. Keep glucose steady within the range your team sets, bring blood pressure to your individual target, take any prescribed lipid-lowering medicine, stop smoking, stay active, and attend every eye check. Early retinopathy can stabilize or improve with sustained control, though the change shows up over check-ups rather than weeks.

Can diabetic retinopathy be reversed?

Early changes such as microaneurysms and mild leakage can sometimes settle when glucose and blood pressure improve, and macular swelling often reduces with treatment. Retina that has been destroyed by lack of blood supply or laser does not regrow, and vision lost to scarring may not return. Realistic goals are stabilizing the retina and protecting the sight you have.

What is the usual diabetic eye exam frequency?

For most people, once a year. The Mayo Clinic recommends an annual dilated exam, and the NHS invites everyone with diabetes aged 12 and over yearly, extending to every 2 years for some people after two consecutive clear results. Pre-proliferative changes may bring checks every 3 or 6 months, and pregnancy usually adds extra exams.

Does pregnancy make diabetic retinopathy worse?

It can speed progression in some women, which is why the Mayo Clinic notes that additional eye exams are often recommended during pregnancy and the NHS screens pregnant women more frequently. Tell your eye team as soon as you are planning or confirm a pregnancy so the check calendar and any treatment plan can be adjusted with your obstetric and diabetes teams.

Can I drive home after a dilated eye exam?

No. Dilating drops leave vision blurred and light-sensitive for several hours, according to the NHS, so arrange a lift or public transport and bring sunglasses. Reading and screen work will be difficult for the rest of the afternoon. Whether your diagnosis or treatment needs to be reported to your driver licensing authority is a separate question worth asking your clinician.

Do eye injections for diabetic retinopathy hurt?

Most people describe pressure rather than pain, because numbing drops are used before the injection. The eye may feel gritty for a day from the antiseptic, and a red spot on the white of the eye is common. Increasing pain, worsening redness or falling vision in the following days is not normal and should be reported straight away.

Is it too late to improve my blood sugar if I already have retinopathy?

No. Better glucose and blood pressure control slows progression at every stage, protects the treated eye from fresh damage, and benefits the kidneys and heart. Because rapid changes can briefly unsettle the retina, tell your eye team when a new regimen starts so they can watch more closely. Your diabetes clinician sets the pace; the goal is steady, not sudden.

References

• NHS: Diabetic retinopathy
• NHS: Diabetic retinopathy, stages
• National Eye Institute (NIH): Diabetic retinopathy

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.